# Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI

> **NCT03084523** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 30 (actual)

## Conditions studied

- Stroke
- Intracranial Atherosclerosis

## Interventions

- **DRUG:** Ferumoxytol Injectable Product

## Key facts

- **NCT ID:** NCT03084523
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-26
- **Primary completion:** 2024-06-03
- **Final completion:** 2024-06-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03084523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03084523, "Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03084523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*